Showing results (11-20 of 28) with videos related to
Sort By:
Pageof 3
International Journal of STD & AIDS|September 20, 2023
Assessing and improving the quality of guideline-adherent hepatitis B virus care in people with HIV: A cross-sectional studyPatrick Ga Oomen, Vincent Jp van Kraaij, Anna M Gerritsma, et al.Open Forum Infectious Diseases|July 16, 2020
Decreased All-Cause and Liver-Related Mortality Risk in HIV/Hepatitis B Virus Coinfection Coinciding With the Introduction of Tenofovir-Containing Combination Antiretroviral TherapyBerend J van Welzen, Colette Smit, Anders Boyd, et al.The Lancet. HIV|August 29, 2024
Real-world effectiveness and tolerability of switching to doravirine-based antiretroviral therapy in people with HIV: a nationwide, matched, prospective cohort studyPatrick G A Oomen, Ferdinand W N M Wit, Kees Brinkman, et al.Open Forum Infectious Diseases|March 10, 2022
Changes in Inflammatory and Atherogenesis Biomarkers With the 2-Drug Regimen Dolutegravir Plus Lamivudine in Antiretroviral Therapy-Experienced, Virologically Suppressed People With HIV-1: A Systematic Literature ReviewJosep M Llibre, Pedro E Cahn, Janet Lo, et al.Journal of Medical Virology|October 20, 2023
Integrated analysis of viral blips, residual viremia, and associated factors in people with HIV: Results from a retrospective cohort studyPatrick G A Oomen, Suzan Dijkstra, L Marije Hofstra, et al.AIDS Research and Human Retroviruses|February 3, 2023
The Effect of Efavirenz on Reward Processing in Asymptomatic People Living with HIV: A Randomized Controlled TrialPatrick G A Oomen, Charlotte S Hakkers, Joop E Arends, et al.Infectious Diseases and Therapy|April 20, 2024
Underlying Neural Mechanisms of Cognitive Improvement in Fronto-striatal Response Inhibition in People Living with HIV Switching Off Efavirenz: A Randomized Controlled BOLD fMRI TrialPatrick G A Oomen, Charlotte S Hakkers, Joop E Arends, et al.Journal of Virus Eradication|March 14, 2022
The perceived impact of an HIV cure by people living with HIV and key populations vulnerable to HIV in the Netherlands: A qualitative studyKim A G J Romijnders, Laura de Groot, Sigrid C J M Vervoort, et al.Scientific Reports|December 19, 2022
The experienced positive and negative influence of HIV on quality of life of people with HIV and vulnerable to HIV in the NetherlandsKim A G J Romijnders, Laura de Groot, Sigrid C J M Vervoort, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 11, 2024
Virological Failure After Switch to Long-Acting Cabotegravir and Rilpivirine Injectable Therapy: An In-depth AnalysisBerend J van Welzen, Steven F L Van Lelyveld, Gerjanne Ter Beest, et al.Pageof 3